Tadalafil in Becker Muscular Dystrophy
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Tadalafil in Becker Muscular Dystrophy is a clinical trial[1].
Key Facts
- Tadalafil in Becker Muscular Dystrophy is in the country of United States[2].
- Tadalafil in Becker Muscular Dystrophy's instance of is recorded as clinical trial[3].
- Tadalafil in Becker Muscular Dystrophy's start time is recorded as +2010-01-31T00:00:00Z[4].
- Tadalafil in Becker Muscular Dystrophy's end time is recorded as +2012-12-31T00:00:00Z[5].
- Tadalafil in Becker Muscular Dystrophy's sponsor is recorded as Cedars-Sinai Medical Center[6].
- Tadalafil in Becker Muscular Dystrophy's number of participants is recorded as {'unit': '1', 'amount': '+48'}[7].
- Tadalafil in Becker Muscular Dystrophy's title is recorded as Functional Muscle Ischemia and PDE5A Inhibition in Becker Muscular Dystrophy[8].
- Tadalafil in Becker Muscular Dystrophy's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[9].
- Tadalafil in Becker Muscular Dystrophy's ClinicalTrials.gov ID is recorded as NCT01070511[10].
- Tadalafil in Becker Muscular Dystrophy's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+55'}[11].
- Tadalafil in Becker Muscular Dystrophy's research intervention is recorded as tadalafil[12].
- Tadalafil in Becker Muscular Dystrophy's clinical trial phase is recorded as phase IV clinical trial[13].
- Tadalafil in Becker Muscular Dystrophy's research site is recorded as Cedars-Sinai Medical Center[14].
- Tadalafil in Becker Muscular Dystrophy's research subject recruitment status is recorded as completed[15].
- Tadalafil in Becker Muscular Dystrophy's study type is recorded as interventional study[16].